Viewing Study NCT03033069


Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2026-01-05 @ 6:28 PM
Study NCT ID: NCT03033069
Status: COMPLETED
Last Update Posted: 2021-12-08
First Post: 2017-01-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 331-201-00061
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View